The Vall d´Hebron Institute of Oncology (VHIO) Seeks a Laboratory Technician to Join its Stem Cells & Cancer Group
Application deadline: 15/01/2020
Number of vacancies: 1
The Vall d´Hebron Institute of Oncology´s (VHIO) Stem Cells & Cancer Group, headed by Héctor G. Palmer, is currently recruiting for a Scientific Laboratory Technician to support projects focused on developing new therapies for the treatment of advanced metastatic and drug-resistant cancer.
To do so, the group is working with mouse models of cancer and mainly with patient-derived xenografts to test combinations of new drugs in collaboration with various pharmaceutical companies.
- A highly organized, motivated, team-oriented individual, who is highly skilled and experienced in working with animal models.
- Specific experience in mouse models of cancer, drug administration and animal surgery will be favorably considered.
- In addition, training in other techniques such as histology, cell culture, western blot or any protocols of molecular biology, will be greatly appreciated.
- Prior completion of an official animal handling course (FELASA) is mandatory.Application:
- Candidates must submit a curriculum vitae and letter of intent addressed to Héctor G. Palmer using the form below or via email to: firstname.lastname@example.org adding “Ref. 34/2019” in the subject line.
Under the leadership of Josep Tabernero, the Vall d’Hebron Institute of Oncology (VHIO), has established itself as a comprehensive cancer center of proven excellence internationally. It is also thanks to VHIO’s optimal organizational structure based on a purely multidisciplinary and translational model that VHIO talents continue to anticipate and tackle the many unresolved questions in combatting this multifaceted and heterogeneous disease.
Located within the Vall d’Hebron Barcelona Hospital Campus, our researchers closely collaborate and interact with Vall d’Hebron physician-scientists. Translational science and clinical research are therefore tightly connected which promotes superb interaction and teamwork which, in turn, accelerates the bench-bedside-bed cycle of knowledge. This privileged environment affords VHIO direct access to patients as well as the entire spectrum of oncology professionals who care for them, and a second-to-none appreciation of how cancer science can translate into more powerful, targeted treatments and better practice for the care of patients.
VHIO’s pioneering model and programs, coupled with its belief in combining strengths through cross-border collaborations, continue to spur advances in reversing cancer resistance, halting metastatic spread, and more effectively treating even the most undruggable tumor types.
VHIO’s translation toward precision oncology: http://www.vhio.net
Vall d’Hebron Institute Oncology (VHIO) endorses the Requirements and Principles of the European Charter for Researchers, the Code of Conduct for the Recruitment of Researchers promoted by the European Commission and follows Equal Opportunities policies.
On 10th April 2018 VHIO was awarded the “HR Excellence in Research” logo. Our Institute was consequently granted permission to use the HR Excellence in Research Award logo as demonstration of its stimulating and favourable work environment in line with the Charter & Code.